La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Cochlear Gestion

Gestion contrôle des critères 4/4

Le PDG Cochlear's est Dig Howitt, nommé en Jul2017, a un mandat de 7.08 ans. La rémunération annuelle totale est A$ 6.45M, composée du salaire de 32.1% et des bonus 67.9%, y compris les actions et options de la société. détient directement 0.083% des actions de la société, d'une valeur de A$ 16.63M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 7.1 ans et 5.7 ans.

Informations clés

Dig Howitt

Directeur général

AU$6.4m

Rémunération totale

Pourcentage du salaire du PDG	32.1%
Durée du mandat du directeur général	7.1yrs
Propriété du PDG	0.08%
Durée moyenne d'occupation des postes de direction	7.1yrs
Durée moyenne du mandat des membres du conseil d'administration	5.7yrs

Mises à jour récentes de la gestion

Recent updates

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

Apr 29

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Mar 20

Insider Buying: The Cochlear Limited (ASX:COH) Independent Non-Executive Director Just Bought 24% More Shares

Mar 02

Cochlear Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 20

Analyse de la rémunération des PDG

Comment la rémunération de Dig Howitt a-t-elle évolué par rapport aux bénéfices de Cochlear?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	AU$6m	AU$2m	AU$357m
Mar 31 2024	n/a	n/a	AU$354m
Dec 31 2023	n/a	n/a	AU$350m
Sep 30 2023	n/a	n/a	AU$326m
Jun 30 2023	AU$6m	AU$2m	AU$301m
Mar 31 2023	n/a	n/a	AU$281m
Dec 31 2022	n/a	n/a	AU$261m
Sep 30 2022	n/a	n/a	AU$275m
Jun 30 2022	AU$5m	AU$2m	AU$289m
Mar 31 2022	n/a	n/a	AU$273m
Dec 31 2021	n/a	n/a	AU$257m
Sep 30 2021	n/a	n/a	AU$291m
Jun 30 2021	AU$5m	AU$2m	AU$324m
Mar 31 2021	n/a	n/a	AU$82m
Dec 31 2020	n/a	n/a	-AU$160m
Sep 30 2020	n/a	n/a	-AU$199m
Jun 30 2020	AU$3m	AU$2m	-AU$238m
Mar 31 2020	n/a	n/a	AU$34m
Dec 31 2019	n/a	n/a	AU$306m
Sep 30 2019	n/a	n/a	AU$291m
Jun 30 2019	AU$4m	AU$2m	AU$277m
Mar 31 2019	n/a	n/a	AU$270m
Dec 31 2018	n/a	n/a	AU$264m
Sep 30 2018	n/a	n/a	AU$255m
Jun 30 2018	AU$3m	AU$2m	AU$246m

Rémunération vs marché: La rémunération totale de Dig ($USD 4.33M ) est dans la moyenne des entreprises de taille similaire sur le marché Australian ($USD 4.21M ).

Rémunération et revenus: La rémunération de Dig a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Dig Howitt (57 yo)

7.1yrs

Titularisation

AU$6,446,856

Compensation

Mr. Diggory William Howitt, also known as Dig, BE (Hons), MBA has been President of Cochlear Limited since July 31, 2017 and its Chief Executive Officer and Managing Director since January 3, 2018. Mr. How...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Diggory Howitt	CEO, MD	7.1yrs	AU$6.45m	0.083% A$ 16.6m
Stuart Sayers	Chief Financial Officer	8.3yrs	AU$2.46m	0.0052% A$ 1.0m
Jan Janssen	Chief Technology Officer	6.8yrs	AU$2.66m	0.0093% A$ 1.9m
Karen O'Driscoll	Chief Information Officer	1.6yrs	pas de données	pas de données
Kristina Devon	Vice President of Investor Relations	no data	pas de données	pas de données
Rob McGrory	Group General Counsel & Company Secretary	less than a year	pas de données	pas de données
Jennifer Stevenson	VP of Corporate Communications & Brand	no data	pas de données	pas de données
Dean Phizacklea	Senior Vice President of Global Strategic Marketing	8.2yrs	pas de données	pas de données
Jennifer Hornery	Senior Vice President of Global People & Culture	7.6yrs	pas de données	pas de données
Greg Bodkin	Senior Vice President of Global Supply Chain	no data	pas de données	pas de données
Anthony Bishop	President of Asia Pacific & Latin America	no data	AU$1.45m	pas de données
Kimberley Simpson	Head of Group Tax	no data	pas de données	pas de données

7.1yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de COH est chevronnée et expérimentée (ancienneté moyenne 7.1 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Diggory Howitt	CEO, MD	6.8yrs	AU$6.45m	0.083% A$ 16.6m
Michael Daniell	Independent Non-Executive Director	4.6yrs	AU$295.72k	0% A$ 0
Catriona Deans	Independent Non-Executive Chairman of the Board	9.6yrs	AU$596.78k	0% A$ 0
Bruce Robinson	Independent Non-Executive Director	7.7yrs	AU$269.01k	0% A$ 0
Karen Lee Penrose	Non-Executive Independent Director	2.1yrs	AU$305.87k	0% A$ 0
Glen Boreham	Independent Non-Executive Director	9.6yrs	AU$293.36k	0% A$ 0
Michael J. Del Prado	Independent Non-Executive Director	2.6yrs	AU$314.99k	0% A$ 0
Christine McLoughlin	Independent Non-Executive Director	3.8yrs	AU$287.65k	0% A$ 0

5.7yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de COH sont considérés comme expérimentés (ancienneté moyenne 5.7 ans).

Cochlear Gestion

Gestion contrôle des critères 4/4

Informations clés

Mises à jour récentes de la gestion

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Key Executive recently bought AU$97k worth of stock

Recent updates

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Upcoming dividend of AU$1.55 per share

Investor sentiment improved over the past week

First half 2022 earnings: EPS and revenues exceed analyst expectations

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited Advises of US Patent Infringement Complaint

Upcoming dividend of AU$1.40 per share

CEO, MD exercised options and sold AU$295k worth of stock

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Independent Non-Executive Director recently bought AU$94k worth of stock

Independent Chairman Roderic Holliday-Smith has left the company

Independent Chairman Roderic Holliday-Smith has left the company

Full year 2021 earnings released: EPS AU$4.97 (vs AU$4.00 loss in FY 2020)